Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Start

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

Previous Story

Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?

Next Story

Oil Prices Jump After Trump’s Latest Iran Threat